Quarterly report pursuant to Section 13 or 15(d)

Condensed Balance Sheets

v3.22.2.2
Condensed Balance Sheets - USD ($)
Jun. 30, 2022
Dec. 31, 2021
Current Assets    
Cash $ 7,808,181 $ 1,479,166
Prepaid expenses 35,537 7,995
Inventory 127,441 121,994
Current Assets 7,971,159 1,609,155
Fixed Assets, net of accumulated depreciation 4,181,099 3,763,332
Other Assets 2,873,864 529,863
TOTAL ASSETS 15,026,122 5,902,350
Current Liabilities    
Accounts payable and accrued liabilities 558,298 804,138
Notes payable, net of discount 700,015
Contingent stock liability 677,000
Warrant liability 2,465,820 585,000
Total Current Liabilities 3,024,118 2,766,153
Commitments and Contingencies (Notes 5 and 14)
Stockholders’ Equity:    
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; 1 share issued and outstanding
Common stock, $0.0001 par value; 100,000,000 shares authorized; 9,207,415 shares issued and outstanding at June 30, 2022 (5,187,062 shares issued and outstanding December 31, 2021) 922 519
Common stock subscription receivable (32,500)
Additional paid-in capital 24,060,753 13,835,882
Accumulated deficit (12,059,671) (10,667,704)
Total Stockholders’ Equity 12,002,004 3,136,197
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 15,026,122 $ 5,902,350